Do you want to read an article? Please log in or register.
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients with Type 2 Diabetes and Diabetic Retinopathy
Retinal Diseases
RECOMMENDED
Related content
Retinal Diseases
Glucagon-like peptide-1 receptor agonists and risk of diabetic retinopathy in type 2 diabetes: A systematic review and network meta-analysis of randomized clinical trials
Surv Ophthalmol
Ortiz-Seller A, Real JT, Morcillo E, Ortiz JL
doi: 10.1016/j.survophthal.2026.08.007
COMMENTED
Retinal Diseases
Ocular Outcomes with Tirzepatide Versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Ophthalmol Retina
Hong AT, Lin F, Keenan JD, Stewart JM
doi: 10.1016/j.oret.2026.02.002
COMMENTED
Macular DiseasesRetinal Diseases
Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists; an examination of the FAERS (FDA Adverse Event reporting System) database
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Am J Ophthalmol
Murray M, Schifano F, Chiappini S, Corkery JM, Guirguis A
doi: 10.1016/j.ajo.2025.12.015
Macular Diseases
Rate of Age-Related Macular Degeneration in Patients Prescribed Glucagon-Like Peptide-1 Receptor Agonists or Other Weight Loss Therapy
Ophthalmol Retina
Myers WK, Heath G, Rohrer B
doi: 10.1016/j.oret.2025.12.016
COMMENTED
Glaucoma and Ocular Pressure
Tirzepatide is Associated with Reduced Risk of Primary Open-Angle Glaucoma and Ocular Hypertension in Patients with Type 2 Diabetes
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Am J Ophthalmol
Hong AT, Lin F, Baxter S, Weinreb RN
doi: 10.1016/j.ajo.2025.12.003
Macular Diseases
Glucagon-Like Peptide-1 Receptor Agonists and Age-Related Macular Degeneration
JAMA Ophthalmol
Ahuja AS, Paredes AA 3rd, Young BK
doi: 10.1001/jamaophthalmol.2025.3821
COMMENTED
Macular Diseases
Impact of Glucagon-like Peptide-1 Receptor Agonists on Age-Related Macular Degeneration at a Tertiary Ophthalmology Center
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Ophthalmol Retina
Joo JH, Zhao AH, Chalasani M, Allan KC, Rachitskaya AV
doi: 10.1016/j.oret.2025.12.014
COMMENTED
Retinal Diseases
Early Worsening of Diabetic Retinopathy Following Initiation of Hybrid Closed-Loop/Automated Insulin Delivery Systems in Type 1 Diabetes: A Systematic Review and Structured Study-Level Synthesis
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Obes Metab
Anson M, Iqbal A, Azmi S, Weston P, Hughes L, Choudhury M, Hughes DM, Zheng Y, Burgess PI, Alam U
doi: 10.1111/dom.71084
Macular DiseasesRetinal Diseases
Racial and ethnic disparities in risk for adverse ocular events in patients with diabetic retinopathy
Am J Ophthalmol
Anozie CC Jr, Cox VF, Wiseman MT Jr, Lewis JE, Garcia AP, Ochoa JM, Williams BK Jr
doi: 10.1016/j.ajo.2025.11.012